Ex vivo detection of rat coronary endothelial dysfunction in diabetes mellitus - Methodological considerations

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 28, Issue 8, 2006, Pages 507-513

  Dobaczewski, M ^a   Kazmierczak, P ^a,b   Ravingerova, T ^c   Ulicna, O ^d   Nocun, M ^a   Waczulikova, I ^e   Markuszewski, L ^a   Watala, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d Comenius University ^*  (Slovakia)

^e Physics and Informatics   (Slovakia)

Author keywords

Constant and corrected rate infusion; Coronary endothelial dysfunction; Diabetes mellitus; Endothelium dependent and independent vasodilatation

Indexed keywords

BRADYKININ; DIETHYLAMINE; NITRIC OXIDE; VASOACTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIABETES MELLITUS; DRUG INFUSION; DRUG TISSUE LEVEL; ENDOTHELIAL DYSFUNCTION; EX VIVO STUDY; EXPERIMENTAL MODEL; HEMODYNAMICS; ISOLATED HEART; MALE; METABOLIC REGULATION; NONHUMAN; RAT; STIMULUS RESPONSE; VASODILATATION;

ANIMALS; BLOOD GLUCOSE; BRADYKININ; C-PEPTIDE; CHOLESTEROL; CORONARY CIRCULATION; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FASTING; HEART; HYDRAZINES; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; PERFUSION; RATS; RATS, WISTAR; TRIGLYCERIDES; VASODILATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33845352094     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2006.28.8.1003575     Document Type: Article

References (34)

1. Creager, M.A., Luscher, T.F., Cosentino, F., Beckman, J.A. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 2003, 108: 1527-32.
2. Luscher, T.F., Creager, M.A., Beckman, J.A., Cosentino, F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 2003, 108: 1655-61.
3. Avogaro, A., Vigili de Kreutzenberg S., Negut, C., Tiengo, A., Scognamiglio, R. Diabetic cardiomyopathy: A metabolic perspective. Am J Cardiol 2004, 93(8A): 13A-16A.
4. Bell, D.S. Diabetic cardiomyopathy. Diabetes Care 2003, 26: 2949-51.
5. Bell, D.S. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease. Diabetes Care 1995, 18: 708-14.
6. Yu, Y., Ohmori, K., Kondo, I. et al. Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats. Cardiovasc Res 2002, 56: 303-11.
7. Kamata, K., Miyata, N., Abiru, T., Kasuya, Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci 1992, 50: 1379-87.
8. Zhu, X.X., Zhou, X.P., Zhong, X.L., Zhong, C.S., Yu, Y.F. Streptozotocin induced cardiomyopathy in diabetic rats. Chin Med J 1993, 106: 463-6.
9. Given, M.B., Greenberg, S.S., Giles, T.D. Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats. Am J Hypertens 2001, 14(5 Pt 1): 446-54.
10. Warner, E.L., Galasso, F., Thompson, C.I., Belloni, F.L. Vasodilative and anti-adrenergic effects of adenosine in diabetic rat hearts. Can J Physiol Pharmacol 1992, 70: 13-9.
11. Reibel, D.K., Roth, D.M., Lefer, B.L., Lefer, A.M. Hyperreactivity of coronary vasculature in platelet-perfused hearts from diabetic rats. Am J Physiol 1983, 245: H640-45.
12. Roth, D.M., Reibet, D.K., Lefer, A.M. Altered coronary vascular responsiveness to leukotrienes in alloxan-diabetic rats. Circ Res 1984, 54: 388-95.
13. Li, X.S., Tanz, R.D., Chang, K.S. Effect of age and methacholine on the rate and coronary flow of isolated hearts of diabetic rats. Br J Pharmacol 1989, 97: 1209-17.
14. Jakubowski, A., Chlopicki, S., Olszanecki, R. et al. Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins Leukot Essent Fatty Acids 2005, 72: 139-45.
15. Bell, D.S. Advances in diabetes for the millennium: The heart and diabetes. MedGenMed 2004, 6: 7.
16. Bell, D.S. Heart failure: The frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 2003, 26: 2433-41.
17. Nesto, R.W. Pharmacological treatment and prevention of heart failure in the diabetic patient. Rev Cardiovasc Med 2004, 5: 1-8.
18. Nahser, P.J., Jr., Brown, R.E., Oskarsson, H., Winniford, M.D., Rossen, J.D. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 1995, 91: 635-40.
19. Arora, G.D., Reeves, W.C., Movahed, A. Alteration of coronary perfusion reserve in hypertensive patients with diabetes. J Hum Hypertens 1994, 8: 51-7.
20. Koltai, M.Z., Hadhazy, P., Posa, I. et al. Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res 1997, 34: 157-63.
21. Nitenberg, A., Valensi, P., Sachs, R., Dali, M., Aptecar, E., Attali, J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 1993, 42: 1017-25.
22. Rosen, P., Ballhausen, T., Stockklauser, K. Impairment of endothelium dependent relaxation in the diabetic rat heart: Mechanisms and implications. Diabetes Res Clin Pract 1996, 31 (Suppl): S143-55.
23. Srivastava, A.K. Hyperglycemia-induced protein kinase signaling pathways in vascular smooth muscle cells: Implications in the pathogenesis of vascular dysfunction in diabetes. Adv Exp Med Biol 2001, 498: 311-8.
24. Gutterman, D.D. Vascular dysfunction in hyperglycemia: Is protein kinase C the culprit. Circ Res 2002, 90: 5-7.
25. Graier, W.F., Posch, K., Fleischhacker, E., Wascher, T.C., Kostner, G.M. Increased superoxide union formation in endothelial cells during hyperglycemia: An adaptive response or initial step of vascular dysfunction? Diabetes Res Clin Pract 1999, 45: 153-60.
26. Chaudhuri, A. Vascular reactivity in diabetes mellitus. Curr Diab Rep 2002, 2: 305-10.
27. Fortes, Z.B., Garcia, Leme J., Scivoletto, R. Influence of diabetes on the reactivity of mesenteric microvessels to histamine, bradykinin and acetylcholine. Br J Pharmacol 1983, 78: 39-48.
28. Sanz, E., Fernandez, N., Monge, L. et al. Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: Gender and regional differences. Life Sci 2003, 72: 1537-47.
29. Ulker, S., McKeown, P.P., Bayraktutan, U. Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells. Cardiovasc Res 2002, 55: 830-7.
30. Brown, I.P., Thompson, C.I., Belloni, F.L. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart. Am J Physiol 1993, 264(3 Pt 2): H821-829.
31. Brown, I.P., Thompson, C.I., Belloni, F.L. Mechanisms of coronary vasodilatation produced by ATP in guinea-pig isolated perfused heart. Br J Pharmacol 1992, 105: 211-5.
32. Miura, H., Wachtel, R.E., Loberiza, F.R., Jr. et al. Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: Reduced activity of ATP-sensitive potassium channels. Circ Res 2003, 92: 151-8.
33. Weintraub, N.L. Impaired hypoxic coronary vasodilation and ATP-sensitive potassium channel function: A manifestation of diabetic microangiopathy in humans. Circ Res 2003, 92: 127-9.
34. Kocsis, E., Pacher, P., Posa, I., Nieszner, E., Pogatsa, G., Koltai, M.Z. Hyperglycaemia alters the endothelium-dependent relaxation of canine coronary arteries. Acta Physiol Scand 2000, 169: 183-7.